Pencil Banner October 16 2023

Elevar Therapeutics and Jiangsu Hengrui Pharma announce global commercialization licensing agreement for camrelizumab in combination with rivoceranib for hepatocellular carcinoma LEARN MORE HERE

Gynecologic Oncology 2020

Gynecologic Oncology: Phase 3 Publication of Efficacy & Safety Results Comparing Paclitaxel Micellar & Cremophor EL-Paclitaxel

This peer-reviewed manuscript was published in Gynecologic Oncology in February 2020. It reviews results from a multicenter, open-label, randomized Phase III trial evaluating the efficacy and safety of paclitaxel micellar (+carboplatin) compared to Cr-EL paclitaxel (+carboplatin) in recurrent platinum-sensitive ovarian, fallopian tube or peritoneal carcinoma. To read the full study report download the publication.